Cytodyn Inc at CytoDyn (OTC: CYDY) June 2 2020 - Livestream Transcript
[Again], welcome, everybody to Wall Street reporters next super stock live stream for today, June 2, 2020. And we have another exclusive presentation today from CytoDyn, which many of you have been following since almost a year now, since we first presented on our live stream in the company's [made] progress, we're going to find out more about the latest news today. Again, (inaudible). Nader is going to present for about 20 minutes and then we're going to open up for Q&A. And he is going to be joined by Dr. Jay Lalezari. So Nader let me turn it over to. Thank you.
Thank you, Jack. Appreciate it and thanks for everyone being on the call. Sorry about the technical difficulties that we had. Today's presentation, like always, we will be making forward-looking statements. Before I start our presentation, I'd like to talk about FDA approval process real quick. Many people have called us e-mailed us that, why are we not getting approval yet. I want to make sure that everybody understands that there is three
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
